tradingkey.logo

Phibro Animal Health Corp

PAHC

30.647USD

+0.527+1.75%
交易中 美东报价延迟15分钟
1.24B总市值
39.07市盈率 TTM

Phibro Animal Health Corp

30.647

+0.527+1.75%
关于 Phibro Animal Health Corp 公司
Phibro Animal Health Corporation 是一家全球多元化动物保健和矿物质营养公司。该公司开发、生产和销售一系列食品和伴侣动物产品,包括家禽、猪、肉牛和奶牛、水产养殖和狗。该公司向 80 多个国家的大约 4,200 名客户销售约 750 条产品线。该公司有三个部门:动物保健、矿物质营养和性能产品。其动物保健部门开发、生产和销售约 280 条产品线,包括抗菌药、抗球虫药和相关产品;营养特种产品;和疫苗。矿物质营养部门包括锌、锰、铜、铁和其他化合物等微量矿物质的配方和浓度,重点关注北美客户。性能产品部门生产和销售用于个人护理、工业化学品和化学催化剂行业的特种成分。
公司简介
公司代码PAHC
公司名称Phibro Animal Health Corp
上市日期Apr 11, 2014
成立日期2014
CEOMr. Jack C. Bendheim
员工数量1940
证券类型Ordinary Share
年结日Apr 11
公司地址Glenpointe Centre East, 3Rd Floor
城市TEANECK
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编07666
电话12013297300
网址https://www.pahc.com/
公司代码PAHC
上市日期Apr 11, 2014
成立日期2014
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
--
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
--
--
Ms. Judith A. Weinstein
Ms. Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
--
--
Ms. Joyce J. Lee
Ms. Joyce J. Lee
Independent Director
Independent Director
--
--
Mr. Todd Armstrong
Mr. Todd Armstrong
President - North American Region
President - North American Region
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
--
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
地区USD
名称
营收
占比
United States
209.94M
60.36%
Latin America and Canada
70.75M
20.34%
Europe & Middle East & Africa
38.91M
11.19%
Asia Pacific
28.22M
8.11%
业务
地区
业务USD
名称
营收
占比
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
15.24%
The Vanguard Group, Inc.
7.45%
State Street Global Advisors (US)
4.52%
Acadian Asset Management LLC
3.84%
Pzena Investment Management, LLC
3.55%
Other
65.40%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
15.24%
The Vanguard Group, Inc.
7.45%
State Street Global Advisors (US)
4.52%
Acadian Asset Management LLC
3.84%
Pzena Investment Management, LLC
3.55%
Other
65.40%
股东类型
持股股东
占比
Investment Advisor
50.21%
Investment Advisor/Hedge Fund
40.46%
Hedge Fund
9.57%
Research Firm
2.71%
Pension Fund
1.84%
Individual Investor
0.45%
Bank and Trust
0.41%
Corporation
0.29%
Sovereign Wealth Fund
0.05%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
373
21.59M
106.02%
-2.97M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
2023Q2
341
20.61M
101.32%
-2.12M
2023Q1
350
20.77M
102.13%
-2.00M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.10M
15.24%
-58.95K
-1.86%
Mar 31, 2025
The Vanguard Group, Inc.
1.52M
7.45%
+6.78K
+0.45%
Mar 31, 2025
State Street Global Advisors (US)
920.19K
4.52%
-26.64K
-2.81%
Mar 31, 2025
Acadian Asset Management LLC
782.94K
3.84%
+4.14K
+0.53%
Mar 31, 2025
Pzena Investment Management, LLC
723.83K
3.55%
-578.95K
-44.44%
Mar 31, 2025
Renaissance Technologies LLC
705.30K
3.46%
+147.50K
+26.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
643.91K
3.16%
-73.20K
-10.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
547.09K
2.69%
+31.11K
+6.03%
Mar 31, 2025
Brandes Investment Partners, L.P.
484.75K
2.38%
-177.22K
-26.77%
Mar 31, 2025
Nuveen LLC
481.80K
2.37%
-105.20K
-17.92%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
Brandes US Small-Mid Cap Value ETF
1.71%
Innovator IBD Breakout Opportunities ETF
1.36%
Inspire Fidelis Multi Factor ETF
1.17%
Invesco S&P SmallCap 600 Pure Growth ETF
0.7%
Lattice Hartford Multifactor Small Cap ETF
0.63%
SPDR S&P Pharmaceuticals ETF
0.61%
Invesco Dorsey Wright SmallCap Momentum ETF
0.4%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.36%
Invesco S&P SmallCap Health Care ETF
0.35%
Zacks Small/Mid Cap ETF
0.28%
查看更多
Brandes US Small-Mid Cap Value ETF
占比1.71%
Innovator IBD Breakout Opportunities ETF
占比1.36%
Inspire Fidelis Multi Factor ETF
占比1.17%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.7%
Lattice Hartford Multifactor Small Cap ETF
占比0.63%
SPDR S&P Pharmaceuticals ETF
占比0.61%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0.4%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比0.36%
Invesco S&P SmallCap Health Care ETF
占比0.35%
Zacks Small/Mid Cap ETF
占比0.28%
分红派息
近5年累计派现 97.17M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
May 01, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 28, 2023 going ex on Jun 06, 2023
Jun 07, 2023
Jun 28, 2023
Jun 06, 2023
Feb 06, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 22, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 22, 2023
Feb 28, 2023
Nov 07, 2022
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 21, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 21, 2022
Nov 29, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI